A combined ANXA2-NDRG1-STAT1 gene signature predicts response to chemoradiotherapy in cervical cancer.
Buttarelli M, Babini G, Raspaglio G, Filippetti F, Battaglia A, Ciucci A, Ferrandina G, Petrillo M, Marino C, Mancuso M, Saran A, Villani ME, Desiderio A, D'Ambrosio C, Scaloni A, Scambia G, Gallo D.
Buttarelli M, et al. Among authors: babini g.
J Exp Clin Cancer Res. 2019 Jun 26;38(1):279. doi: 10.1186/s13046-019-1268-y.
J Exp Clin Cancer Res. 2019.
PMID: 31242951
Free PMC article.